195 related articles for article (PubMed ID: 12438334)
1. Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.
Pietrella D; Mazzolla R; Lupo P; Pitzurra L; Gomez MJ; Cherniak R; Vecchiarelli A
Infect Immun; 2002 Dec; 70(12):6621-7. PubMed ID: 12438334
[TBL] [Abstract][Full Text] [Related]
2. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A
Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.
Montagnoli C; Sandini S; Bacci A; Romani L; La Valle R
Med Mycol; 2004 Aug; 42(4):319-24. PubMed ID: 15473356
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response.
Fidel PL; Murphy JW
Infect Immun; 1990 Feb; 58(2):393-8. PubMed ID: 2105273
[TBL] [Abstract][Full Text] [Related]
5. An early imbalance of interleukin 12 influences the adjuvant effect of mannoproteins of Cryptococcus neoformans.
Pietrella D; Lupo P; Bistoni F; Vecchiarelli A
Cell Microbiol; 2004 Sep; 6(9):883-91. PubMed ID: 15272868
[TBL] [Abstract][Full Text] [Related]
6. Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.
Nichols KL; Bauman SK; Schafer FB; Murphy JW
Infect Immun; 2002 Feb; 70(2):591-600. PubMed ID: 11796587
[TBL] [Abstract][Full Text] [Related]
7. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
Mody CH; Paine R; Jackson C; Chen GH; Toews GB
J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection.
Garro AP; Chiapello LS; Baronetti JL; Masih DT
Immunology; 2011 Oct; 134(2):198-213. PubMed ID: 21896014
[TBL] [Abstract][Full Text] [Related]
9. Effects of Cryptococcus neoformans-specific suppressor T cells on the amplified anticryptococcal delayed-type hypersensitivity response.
Buchanan KL; Fidel PL; Murphy JW
Infect Immun; 1991 Jan; 59(1):29-35. PubMed ID: 1824761
[TBL] [Abstract][Full Text] [Related]
10. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
11. CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.
Gaspari AA; Burns R; Nasir A; Ramirez D; Barth RK; Haidaris CG
Infect Immun; 1998 Sep; 66(9):4440-9. PubMed ID: 9712799
[TBL] [Abstract][Full Text] [Related]
12. 18β-glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract.
Kim J; Joo I; Kim H; Han Y
Phytomedicine; 2013 Aug; 20(11):951-5. PubMed ID: 23746951
[TBL] [Abstract][Full Text] [Related]
13. Mannoproteins from Candida albicans elicit a Th-type-1 cytokine profile in human Candida specific long-term T cell cultures.
La Sala A; Urbani F; Torosantucci A; Cassone A; Ausiello CM
J Biol Regul Homeost Agents; 1996; 10(1):8-12. PubMed ID: 9049775
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
Garner RE; Domer JE
Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.
Moragues MD; Omaetxebarria MJ; Elguezabal N; Sevilla MJ; Conti S; Polonelli L; Pontón J
Infect Immun; 2003 Sep; 71(9):5273-9. PubMed ID: 12933874
[TBL] [Abstract][Full Text] [Related]
16. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.
Romani L; Mocci S; Bietta C; Lanfaloni L; Puccetti P; Bistoni F
Infect Immun; 1991 Dec; 59(12):4647-54. PubMed ID: 1682265
[TBL] [Abstract][Full Text] [Related]
17. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.
Mizutani S; Endo M; Ino-Ue T; Kurasawa M; Uno Y; Saito H; Onogi K; Kato I; Takesako K
Antimicrob Agents Chemother; 2000 Oct; 44(10):2653-8. PubMed ID: 10991839
[TBL] [Abstract][Full Text] [Related]
19. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
[TBL] [Abstract][Full Text] [Related]
20. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.
Murphy JW; Schafer F; Casadevall A; Adesina A
Infect Immun; 1998 Jun; 66(6):2632-9. PubMed ID: 9596727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
